We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

157 hedge funds and large institutions have $817M invested in Intersect ENT, Inc in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more call options, than puts

Call options by funds: $5.8M | Put options by funds: $696K

142% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 12

12% more funds holding

Funds holding: 140 → 157 (+17)

4% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 52

3% more capital invested

Capital invested by funds: $792M → $817M (+$25.3M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
157
Holders Change
+17
Holders Change %
+12.14%
% of All Funds
3.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
54
Reduced
52
Closed
12
Calls
$5.8M
Puts
$696K
Net Calls
+$5.1M
Net Calls Change
+$322K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$15.3M
2
Jennison Associates
Jennison Associates
New York
+$11.2M
3
DM
Deerfield Management
New York
+$7.75M
4
TA
Teachers Advisors
New York
+$6.66M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.09M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$33.6M
2
PHS
PFM Health Sciences
California
-$23.9M
3
EI
EAM Investors
California
-$3.99M
4
CM
Castleark Management
Illinois
-$3.52M
5
PVI
Pura Vida Investments
New York
-$3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$5.89M -$1.74M -58,053 -24%
DCM
27
Driehaus Capital Management
Illinois
$5.82M -$463K -15,456 -8%
FLAM
28
First Light Asset Management
Minnesota
$5.8M +$261K +8,699 +5%
Invesco
29
Invesco
Georgia
$5.76M +$1.31M +43,708 +33%
BIM
30
Bogle Investment Management
Massachusetts
$5.47M -$1.67M -55,776 -25%
WRF
31
Waddell & Reed Financial
Kansas
$5.41M +$291K +9,700 +6%
CM
32
Castleark Management
Illinois
$5.39M -$3.52M -117,420 -41%
Charles Schwab
33
Charles Schwab
California
$5.21M +$1.36M +45,444 +39%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$5.06M -$755K -25,190 -14%
Two Sigma Investments
35
Two Sigma Investments
New York
$4.68M +$1.28M +42,558 +42%
Morgan Stanley
36
Morgan Stanley
New York
$4.5M -$2.22M -74,075 -35%
TCIM
37
TIAA CREF Investment Management
New York
$4.45M +$294K +9,792 +8%
Allianz Asset Management
38
Allianz Asset Management
Germany
$4.1M -$45.6K -1,519 -1%
CWG
39
C WorldWide Group
Denmark
$4.08M -$625K -20,836 -14%
OAM
40
Oxford Asset Management
United Kingdom
$3.86M +$1.2M +40,161 +51%
Citadel Advisors
41
Citadel Advisors
Florida
$3.36M +$1.95M +65,017 +168%
Jacobs Levy Equity Management
42
Jacobs Levy Equity Management
New Jersey
$3.36M +$1.75M +58,260 +128%
PVI
43
Pura Vida Investments
New York
$3.24M -$3M -100,000 -50%
Fiera Capital (Canada)
44
Fiera Capital (Canada)
Quebec, Canada
$3.24M -$601K -20,048 -17%
RA
45
Royce & Associates
New York
$3.05M – – –
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$3.03M -$1.32M -43,969 -32%
RJA
47
Raymond James & Associates
Florida
$2.92M -$82.4K -2,747 -3%
Wells Fargo
48
Wells Fargo
California
$2.74M +$990K +33,007 +64%
MOACM
49
Mutual of America Capital Management
New York
$2.67M -$216K -7,217 -8%
IHM
50
Iguana Healthcare Management
New York
$2.43M -$450K -15,000 -17%
1
2
3 4 5

XENT Hedge Fund Activity: Q4 2017 in Review

157 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2017, worth a combined $817M — up 3.2% from $792M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new XENT positions and 12 closed out — a net gain of 17 holders — while 54 added to existing stakes and 52 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $15.3M. The largest seller was Fidelity Investments, cutting an estimated $33.6M.

  • 157 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2017, up from 140 in Q3 2017.
  • Funds reported $817M of Intersect ENT, Inc stock for Q4 2017, up 3.2% quarter-over-quarter.
  • 29 funds opened new Intersect ENT, Inc positions in Q4 2017 and 12 closed out, a net change of +17 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2017 was Point72 Asset Management, an estimated $15.3M added.
  • The largest Intersect ENT, Inc seller in Q4 2017 was Fidelity Investments, an estimated $33.6M sold.

Based on aggregated 13F filings for Q4 2017.